Supply Of 6 Anti Cancer ( Generic ) Drugs On Rate Contract Basis To Rcc

Work Description - Supply Of 6 Anti Cancer ( Generic ) Drugs From The Original Manufacturers And Direct Importers On Rate Contract Basis To Rcc

The Regional Cancer Centre, a State Govt. and UT organization, invites open tenders (Reference Number: 14/RCC/2026-27/E9983/P2, Tender ID: 2026_RCC_853305_1) for the supply of 6 Anti-Cancer (Generic) Drugs from original manufacturers and direct importers on a rate contract basis. This tender encompasses supplying these medicines to the Regional Cancer Centre in Thiruvananthapuram, Kerala. The estimated tender value is not available. Prospective bidders are required to submit a fixed EMD of ₹10,000.00, and a tender fee of ₹11,534.00 inclusive of GST, and can download tender documents starting May 30, 2026, at 11:15 AM. The deadline for document download and bid submission is June 12, 2026, at 5:00 PM. The bid opening date is scheduled for June 15, 2026, at 11:00 AM. Bidders must provide Notary attested copies of audited accounts, drug manufacturing licenses, GMP and non-conviction certificates, market standing certificates, tender documents, affidavits, bank details, undertakings, compliance statements, and agreement papers as detailed in the tender documents. All documents, including the BOQ-Price Bid, are to be submitted in two covers as specified in the tender documents. This procurement follows a rate contract model, with a work period of 45 days and a bid validity of 365 days. Tender clarifications can be sought between May 30, 2026, and June 12, 2026.